|
|
Article: Summa Medical licenses rights to blood clot imaging agent. (Medi-Physics Inc.)
- Article from:
- PR Newswire
- Article date:
- October 15, 1987
CopyrightCOPYRIGHT 1987 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SUMMA MEDICAL LICENSES RIGHTS TO BLOOD CLOT IMAGING AGENT
ALBUQUERQUE, N.M., Oct. 15 /PRNewswire/ --On Oct. 9, Summa Medical Corp. (NASDAQ: SUMA) and Medi-Physics Inc. (MPI) signed an agreement giving MPI sole and exclusive worldwide rights to Summa's investigational monoclonal antibody-based blood-clot imaging agent. MPI is a wholly owned subsidiary of Hoffman La Roche Inc., a leader in the health-care industry. Under the agreement, MPI will pay Summa an undisclosed amount of cash and a royalty on all adjusted gross sales in the United States and abroad.
Officials at Summa say that the product, known as Summa-Clot or SC-101, is being investigated ...